Yogesh Dwivedi
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (12)
Long non-coding RNAs (lncRNAs) have emerged as critical regulators of gene expression, particularly in complex neuropsychiatric disorders such as major depressive disorder (MDD). This study investigates the expression of lncRNAs in the dorsolateral prefrontal cortex (dlPFC) of MDD subjects and their potential roles in chromatin remodeling and gene silencing. Following the 8×60 K microarray platform, we profiled the expression of 35,003 lncRNAs in 59 MDD and 41 control subjects, identifying 1625 upregulated and 1439 downregulated lncRNAs in the MDD group. Co-expression network analysis revealed a complex and interconnected lncRNA network in MDD, suggesting intricate regulatory mechanisms. Furthermore, by employing the PIRCh-seq technique, we found that a subset of 60 upregulated lncRNAs in the MDD brain interacts with heterochromatic regions marked by the H3K27me3 modification, thereby silencing gene expression. These lncRNAs were associated with 24 downregulated protein-coding genes linked to neuronal functions, including synaptic vesicle exocytosis and neurotransmitter release. Gene ontology and pathway analyses highlighted disruptions in critical neurobiological functions, with particular emphasis on synaptic and neuronal signaling pathways. Our findings underscore the role of lncRNA-mediated heterochromatization in the pathophysiology of MDD, offering novel insights into the epigenetic regulation of brain function and behavior.
Year:
2025
Major depressive disorder (MDD) is strongly linked to chronic stress, yet its molecular mechanisms remain poorly understood. We hypothesize that chronic stress induces epigenetic alterations in stress-associated genes, contributing to transcriptional dysregulation in the prefrontal cortex (PFC), a key brain region implicated in MDD. To test this, we performed expression levels of stress-associated genes in the PFC of rats subjected to restraint stress, which revealed significant downregulation of CRHR2 and NR3C1 , both critical regulators of the hypothalamic–pituitary–adrenal (HPA) axis, as well as a trend to decreased expression of BDNF and TRKB , central mediators of synaptic plasticity. Given the well-established role of miRNAs in gene regulation, we further investigated stress-associated miRNA expression changes and identified miR-20b-3p and miR-425-3p as significantly upregulated in the restraint-stressed group. Bioinformatics analysis predicted miR-20b-3p as a potential regulator of NR3C1 , a relationship confirmed through RISC-mediated immunoenrichment, demonstrating increased miR-20b-3p binding to NR3C1 in stress-exposed rats. To confirm this interaction, we performed parallel analyses in cells ectopically expressing miR-20b-3p mimic, inhibitor, and a non-oligo control. Cells mimicking endogenous miR-20b-3p showed upregulated NR3C1 binding enrichment compared to non-transfected controls, while anti-miR-20b-3p treatment repressed its interaction with the NR3C1 3'UTR. These findings suggest that miR-20b-3p actively engages with NR3C1 and plays a regulatory role in its expression. Collectively, these results highlight a potential epigenetic mechanism by which chronic stress alters NR3C1 expression, possibly contributing to HPA axis dysregulation in MDD. The identification of miR-20b-3p as a key regulator of NR3C1 provides new insights into stress-induced molecular changes and suggests potential therapeutic targets for stress-associated psychiatric disorders.
Year:
2025
Stress significantly impacts brain function and is a major contributor to major depressive disorder. This study explores the role of long noncoding RNAs (lncRNAs) in stress-induced chromatin remodeling and gene regulation, particularly in the context of glucocorticoid receptor (GR) activation, a hallmark of stress-related disorders. Using a cellular model, GR activation regulated 79 lncRNAs: 44 upregulated and 35 downregulated. Chromosome-wise analyses of lncRNA regulation revealed complex patterns, with specific chromosomes, chr1 and chr15, showing a higher prevalence of downregulated genes, while chr11 and chr12 exhibited upregulated genes, indicating the differential roles of lncRNAs in gene silencing and activation. The differentially regulated lncRNAs were further classified into intergenic, overlap_antisense and overlap_sense, revealing their diverse roles in regulating gene expression. An immunoprecipitated ribonucleoprotein assay followed by sequencing confirmed the interaction of lncRNAs with a histone methyltransferase primarily targeting histone H3 lysine 27 (H3K27), with 87 lncRNAs enriched in the pull-down group, and 51 enriched in the EZH2 pull-down, a part of Polycomb Repressive Complex 2 (PRC2), linking these lncRNAs to PRC2-mediated chromatin repression. An integrative analysis revealed an inverse correlation between specific lncRNAs and the transcriptional activity of proximal genes, supporting the role of lncRNAs in gene silencing. Gene ontology of suppressed genes highlighted enrichment in functions related to neuronal death and synaptic transmission. Altogether, our study demonstrates that lncRNAs, particularly those interacting with PRC2, may serve as potential mediators of stress-induced neuronal changes by influencing chromatin accessibility, and potentially highlight their roles in stress-related disorders.
Year:
2025
Long non-coding RNAs (lncRNAs) have emerged as pivotal epigenetic regulators that influence chromatin structure, gene expression, and various cellular processes. We conducted a comprehensive transcriptomic analysis to explore the regulatory roles of lncRNAs in gene expression across major cell types. Based on the cell type abundance as predicted by CIBERSORTx, the gene expression deconvolution of lncRNAs and mRNAs obtained from nonpsychiatric control (n=41) and MDD (n=59) subjects was carried out using bMIND. LncRNA regulatory activity and functional enrichment analysis were assessed in each cell type. Interactions between lncRNAs and transcription factors and RNA-binding proteins, as well as their associations with DNA and RNA, were obtained from the RNA Interactome Database. The protein-protein interactions of lncRNA-regulated mRNAs and the associations between genes and psychiatric disorders were sourced from STRING network PsyGeNET databases, respectively. We observed a prevalence of inhibitory neurons in the control group and a higher proportion of excitatory neurons within the MDD group. A significant dysregulation of lncRNAs and mRNAs, characterized by distinct gene-silencing activity of lncRNAs, was observed, potentially facilitated through chromatin modifications in excitatory and inhibitory neurons, as well as enhancer activity of specific lncRNAs in both neuronal and glial cell types. Functional analyses of the silenced neuronal genes highlighted the involvement of cell adhesion molecules and stress-related signaling in MDD, indicating disrupted neuron-glia interactions. The enhancer activity of lncRNAs indicated the positive regulation of genes involved in Hippo signaling and neurodegeneration. This work uniquely highlights the cell-type-specific roles of lncRNAs and their contributions to MDD pathophysiology. HIGHLIGHTS Comprehensive cell-type-specific transcriptomic analysis of dorsolateral prefrontal cortex in MDD subjects. Distinct gene-silencing activity of lncRNAs in excitatory and inhibitory neurons. Enhancer activity of specific lncRNAs in both neuronal and glial cell types. Critical roles of lncRNAs and associated cellular functions in the pathophysiology of MDD.
Year:
2025
Background Mitochondria play a pivotal role in energy production, and their dysfunction not only hampers cells’ ability to meet energy requirements but also contributes to the impairment of neural plasticity, a critical feature of depressive disorders. In this study, mitochondrial cross-omics analysis was carried out in the hippocampus of restraint rats to understand the role of mitochondria in depression pathophysiology. Methods The expression profiles of hippocampal mitochondrial and nuclear-encoded genes in mitochondrial fractions from restraint and handled control rats were obtained using high-throughput RNA sequencing. Weighted gene co-expression network analysis (WGCNA) was used to identify the gene co-expression and pathways associated with the restraint phenotype. Mutual Information Network algorithm tools Arance, CLR, and MRNET were additionally used to screen the functional modules and hub genes and their similarity with the WGCNA-based network analysis. Finally, cross-species homology followed by gene association analysis was conducted to obtain SNPs and haplotypes related to depression phenotype. Results A significant proportion of mitochondrial and nuclear-encoded genes showed differential regulation in the hippocampus of restraint rats. WGCNA and Mutual Information Network analysis yielded distinct functional modules significantly related to restraint phenotype. Further network analysis revealed distinct co-expression patterns associated with differentially expressed genes associated with these modules. Cross-species analysis showed 39 significantly associated SNPs with the depression phenotype, where the most significant SNP, rs10899570, was located within the TENM4 gene. Further, rs1573529 and rs10899570 were distributed into the linkage disequilibrium block where SNPs were highly correlated. Subsequent haplotype analysis showed that rs1573529 and rs10899570 were significantly associated with depressive behavior. Conclusions The study demonstrates a significant impact of restraint stress on mitochondrial functions and genetic association, suggesting their critical role in depression pathophysiology.
Year:
2025
Major depressive disorder (MDD) is the most prevalent psychiatric disorder. MDD patients are at substantially increased risk of dying by suicide. The molecular mechanisms associated with MDD and associated suicide are not clearly understood, which impedes the development of novel therapeutics. N6-methyladenosine (m6A) is the most prevalent epitranscriptomic mark on mRNA and plays significant roles in various physiological processes. This study investigated m6A RNA methylation and its potential contributions to MDD pathogenesis and associated suicide risk. High-throughput microarray analysis in the dorsolateral prefrontal cortex (dlPFC) of MDD subjects ( n = 49) and non-psychiatric controls ( n = 49) identified 1290 significantly hypermethylated and 6842 hypomethylated transcripts, with most m6A sites enriched in coding sequences. Chromosome-wide analysis showed hypermethylation hotspots on chromosomes 1 and 19. In-silico analysis identified enriched AAGA and ACCCA m6A motifs in the MDD group. Expression analysis revealed reduced FTO demethylase and increased METTL3 methyltransferase levels. A majority of M6A hypermethylated genes showed inverse correlation with their expression levels. Functional enrichment of hypermethylated genes highlighted disruptions in molecular pathways relevant to MDD. Comparison of MDD-non-suicide ( n = 32) and MDD-suicide ( n = 17) identified 6750 transcripts with significant hypermethylation, whereas 6159 transcripts had significant hypomethylation in the MDD-suicide group; of them, 196 hypermethylated genes were explicitly associated with suicide in the MDD group, whereas 38 hypermethylated genes appeared to elevate suicide risk in MDD patients. Also, the MDD-suicide group had distinct neuromolecular pathways associated with these risk genes. Collectively, the findings suggest a critical role for m6A methylation in modulating the molecular networks underlying MDD and suicide susceptibility.
Year:
2025
Epigenetics plays a central role in neuropsychiatric disorders, contributing significantly to their complexity and manifestation. Major depressive disorder (MDD) and bipolar disorder (BD) have profound impact on mood, affect and cognition. Emerging evidence suggests that epigenetic modification of genes plays a pivotal role in the pathogenesis of both MDD and BD. Long non‐coding RNAs (lncRNA) constitute a heterogeneous class of transcripts and have emerged as crucial regulators of epigenetic processes, offering promising insights into the pathophysiology of various diseases. Despite their limited coding potential, lncRNAs are known to play a critical role in achieving global transcriptomic regulation in a spatiotemporal fashion, especially in complex tissue like the brain. This review aims to discuss the specific dysregulation of lncRNAs so far observed in the brains of MDD and BD patients and understand their mechanistic contributions to the disease pathogenesis. Key points Brain‐centric lncRNAs regulate gene networks, and their disruption is linked to MDD. In MDD, altered lncRNAs disrupt gene regulation by changing chromatin looping or modifying chromatin accessibility. These changes lead to neuronal dysfunction, affecting neural circuitry and synaptic plasticity. The result is impaired brain function, contributing to the symptoms of MDD.
Year:
2025
Major depressive disorder (MDD) is a debilitating disorder. Suicide attempts are 5-times higher in MDD patients than in the general population. Interestingly, not all MDD patients develop suicidal thoughts or complete suicide. Thus, it is important to study the risk factors that can distinguish suicidality among MDD patients. The present study examined if DNA methylation changes can distinguish suicidal behavior among depressed subjects. Genome-wide DNA methylation was examined in the dorsolateral prefrontal cortex of depressed suicide (MDD+S; n = 15), depressed non-suicide (MDD−S; n = 17), and nonpsychiatric control (C; n = 16) subjects using 850 K Infinium Methylation EPIC BeadChip. The significantly differentially methylated genes were used to determine the functional enrichment of genes for ontological clustering and pathway analysis. Based on the number of CpG content and their relative distribution from specific landmark regions of genes, 32,958 methylation sites were identified across 12,574 genes in C vs. MDD+/−S subjects, 30,852 methylation sites across 12,019 genes in C vs. MDD−S, 41,648 methylation sites across 13,941 genes in C vs. MDD+S, and 49,848 methylation sites across 15,015 genes in MDD−S vs. MDD+S groups. A comparison of methylation sites showed 33,129 unique methylation sites and 5451 genes in the MDD−S group compared to the MDD+S group. Functional analysis suggested oxytocin, GABA, VGFA, TNFA, and mTOR pathways associated with suicide in the MDD group. Altogether, our data show a distinct pattern of DNA methylation, the genomic distribution of differentially methylated sites, gene enrichment, and pathways in MDD suicide compared to non-suicide MDD subjects.
Year:
2024
Early life is a highly sensitive period associated with profound changes in brain structure and function. Adverse experiences of early-life stress (ELS) are prominent risk factors for the precipitation of major depressive disorder (MDD). In recent years, dysfunction of the central noradrenergic (NA) system and subsequent deficits in norepinephrine (NE) signaling have gained increasing attention in the pathophysiology of MDD. However, the role of the α-2A adrenergic receptor and its downstream second messenger signaling system has not been investigated in connection to early-life stress-induced depression, limiting valuable insights into neurobiological mechanisms underlying this disorder. In this study, we used maternal separation (MS) as a rodent model of ELS to investigate whether ELS-induced depressive behavior is related to the α-2A adrenergic receptor and its associated second messenger signaling cascade. To do so, we studied expression levels of the α-2A adrenergic receptor ( Adra2a ), G alpha proteins (stimulatory subunit-G αs [ Gnas ] and inhibitory subunit-G αi [ Gnai1 and Gnai2 ]), and downstream protein kinase A (PKA) catalytic [ Prkarc α and Prkarcβ ] and regulatory subunits [ Prkar1α , Prkar1β , Prkar2α , and Prkar2β ]) in the frontal cortex (FC) of MS rats. We found reduced sucrose preference in MS animals, along with reduced transcript levels of Adra2a , Gnai2 , Prkar1β , and Prkarcβ . These findings suggest that ELS exposure may contribute to depression symptomatology via alterations in the expression of key genes involved in the NA system, highlighting potential mechanisms underlying ELS-induced depressive behavior.
Year:
2024
Dr. Yogesh Dwivedi is the Elesabeth Ridgely Shook Endowed Chair and Professor in the Department of Psychiatry and Behavioral Neurobiology at the University of Alabama at Birmingham (UAB). He joined UAB in 2013 after working at the University of Illinois at Chicago for about 20 years, where he rose to tenured Professor. He is the Vice Chair for Faculty Affairs and Faculty Development, Co-Director of the UAB Depression and Suicide Center, Director of Translational Research of the UAB Mood Disorder Program, and the Director of the Alabama Brain Bank. He has published over 160 papers in peer-reviewed journals and serves on the editorial board of several scientific journals. He leads multiple National Institute of Mental Health-funded studies and has also edited a book entitled The Neurobiological Basis of Suicide . The recipient of several national and international awards, Dr. Dwivedi is a member of the Scientific Council of the American Foundation for Suicide Prevention and a Fellow of the American College of Neuropsychopharmacology (ACNP), International College of Neuropsychopharmacology (CINP), and International Neuropsychiatric Association. His research broadly elucidates the molecular and cellular mechanisms associated with early-life stress, mood disorders, and suicidal behavior by integrating basic and clinical neuroscience. More specifically, his studies focus on gene regulation through epigenetic, epitranscriptomic, and non-coding RNAs and whether these mechanisms play a role in mood regulation and suicidal behavior. He is also working on translating these findings into biomarkers for depression, suicidality, and treatment response. Dr. Yogesh Dwivedi kindly agreed to engage in the Genomic Press Interview, sharing his distinctive blend of personal and professional narratives.
Year:
2024
Year:
2024
Year:
2023
Collaborators (1)
Shinichiro Ochi
Ehime University
Make your next move.
Prepare your application
Review drafts before you send them.